These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19047650)

  • 21. Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities.
    Brelot A; Heveker N; Montes M; Alizon M
    J Biol Chem; 2000 Aug; 275(31):23736-44. PubMed ID: 10825158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ampelopsin, a small molecule inhibitor of HIV-1 infection targeting HIV entry.
    Liu DY; Ye JT; Yang WH; Yan J; Zeng CH; Zeng S
    Biomed Environ Sci; 2004 Jun; 17(2):153-64. PubMed ID: 15386941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor.
    Doranz BJ; Grovit-Ferbas K; Sharron MP; Mao SH; Goetz MB; Daar ES; Doms RW; O'Brien WA
    J Exp Med; 1997 Oct; 186(8):1395-400. PubMed ID: 9334380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4.
    Schols D; Struyf S; Van Damme J; Esté JA; Henson G; De Clercq E
    J Exp Med; 1997 Oct; 186(8):1383-8. PubMed ID: 9334378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1.
    Taylor JR; Kimbrell KC; Scoggins R; Delaney M; Wu L; Camerini D
    J Virol; 2001 Sep; 75(18):8752-60. PubMed ID: 11507220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The candidate sulfonated microbicide, PRO 2000, has potential multiple mechanisms of action against HIV-1.
    Huskens D; Vermeire K; Profy AT; Schols D
    Antiviral Res; 2009 Oct; 84(1):38-47. PubMed ID: 19664662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of an HIV-1 neutralizing peptide mimicking the CXCR4 and CCR5 surface from the heavy-chain complementary determining region 3 repertoire of a viremic controller.
    Chevigne A; Delhalle S; Counson M; Beaupain N; Rybicki A; Verschueren C; Staub T; Schmit JC; Seguin-Devaux C; Deroo S
    AIDS; 2016 Jan; 30(3):377-82. PubMed ID: 26760231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NeoR6 inhibits HIV-1-CXCR4 interaction without affecting CXCL12 chemotaxis activity.
    Lapidot A; Peled A; Berchanski A; Pal B; Kollet O; Lapidot T; Borkow G
    Biochim Biophys Acta; 2008 Jun; 1780(6):914-20. PubMed ID: 18410746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple determinants are involved in HIV coreceptor use as demonstrated by CCR4/CCL22 interaction in peripheral blood mononuclear cells (PBMCs).
    Agrawal L; Vanhorn-Ali Z; Alkhatib G
    J Leukoc Biol; 2002 Nov; 72(5):1063-74. PubMed ID: 12429730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular pharmacology of AMD11070: an orally bioavailable CXCR4 HIV entry inhibitor.
    Mosi RM; Anastassova V; Cox J; Darkes MC; Idzan SR; Labrecque J; Lau G; Nelson KL; Patel K; Santucci Z; Wong RS; Skerlj RT; Bridger GJ; Huskens D; Schols D; Fricker SP
    Biochem Pharmacol; 2012 Feb; 83(4):472-9. PubMed ID: 22146583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugates.
    Hegde R; Borkow G; Berchanski A; Lapidot A
    FEBS J; 2007 Dec; 274(24):6523-36. PubMed ID: 18028446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of HIV Coreceptor Derived Peptides That Inhibit Viral Entry at Submicromolar Concentrations.
    Bobyk KD; Mandadapu SR; Lohith K; Guzzo C; Bhargava A; Lusso P; Bewley CA
    Mol Pharm; 2017 Aug; 14(8):2681-2689. PubMed ID: 28494151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides.
    Heveker N; Montes M; Germeroth L; Amara A; Trautmann A; Alizon M; Schneider-Mergener J
    Curr Biol; 1998 Mar; 8(7):369-76. PubMed ID: 9545196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection.
    Venzke S; Michel N; Allespach I; Fackler OT; Keppler OT
    J Virol; 2006 Nov; 80(22):11141-52. PubMed ID: 16928758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of highly active antiretroviral treatment on expression of HIV-1 coreceptors and ligand levels in peripheral blood from HIV-1 infected patients in China.
    Fang J; Bai S; Wu L; Zhu X; Yao X; Jin C; Wang C
    J Int Med Res; 2013 Oct; 41(5):1560-9. PubMed ID: 24043708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel role for tumor necrosis factor-alpha in regulating susceptibility of activated CD4+ T cells from human and nonhuman primates for distinct coreceptor using lentiviruses.
    Brice GT; Mayne AE; Villinger F; Ansari AA
    J Acquir Immune Defic Syndr; 2000 May; 24(1):10-22. PubMed ID: 10877490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase of R5 HIV-1 infection and CCR5 expression in T cells treated with high concentrations of CXCR4 antagonists and SDF-1.
    Gotoh K; Yoshimori M; Kanbara K; Tamamura H; Kanamoto T; Mochizuki K; Fujii N; Nakashima H
    J Infect Chemother; 2001 Mar; 7(1):28-36. PubMed ID: 11406754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marked increase in anti-HIV activity, as well as inhibitory activity against HIV entry mediated by CXCR4, linked to enhancement of the binding ability of tachyplesin analogs to CXCR4.
    Xu Y; Tamamura H; Arakaki R; Nakashima H; Zhang X; Fujii N; Uchiyama T; Hattori T
    AIDS Res Hum Retroviruses; 1999 Mar; 15(5):419-27. PubMed ID: 10195751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus.
    Leslie GJ; Wang J; Richardson MW; Haggarty BS; Hua KL; Duong J; Secreto AJ; Jordon AP; Romano J; Kumar KE; DeClercq JJ; Gregory PD; June CH; Root MJ; Riley JL; Holmes MC; Hoxie JA
    PLoS Pathog; 2016 Nov; 12(11):e1005983. PubMed ID: 27855210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient inhibition of SDF-1alpha-mediated chemotaxis and HIV-1 infection by novel CXCR4 antagonists.
    Iwasaki Y; Akari H; Murakami T; Kumakura S; Dewan MZ; Yanaka M; Yamamoto N
    Cancer Sci; 2009 Apr; 100(4):778-81. PubMed ID: 19245436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.